September

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? Harari Sergio, Humbert Marc, Blasi Francesco, Collard Harold R., Matucci-Cerinic Marco, Simonneau Gerald, Vancheri Carlo, Wells Athol U., Cottin Vincent Eur Respir Rev 2015; 24: 375-377
Integration of interventional bronchoscopy in the management of lung cancer Guibert Nicolas, Mazieres Julien, Marquette Charles-Hugo, Rouviere Damien, Didier Alain, Hermant Christophe Eur Respir Rev 2015; 24: 378-391
Coagulation and anticoagulation in idiopathic pulmonary fibrosis Crooks Michael G., Hart Simon P. Eur Respir Rev 2015; 24: 392-399
Pulmonary hypertension in patients with chronic myeloproliferative disorders Adir Yochai, Elia Davide, Harari Sergio Eur Respir Rev 2015; 24: 400-410
Interstitial lung disease in systemic sclerosis: where do we stand? Cappelli Susanna, Bellando Randone Silvia, Camiciottoli Gianna, De Paulis Amato, Guiducci Serena, Matucci-Cerinic Marco Eur Respir Rev 2015; 24: 411-419
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences Harari Sergio, Caminati Antonella Eur Respir Rev 2015; 24: 420-427
Smoking and interstitial lung diseases Margaritopoulos George A., Vasarmidi Eirini, Jacob Joseph, Wells Athol U., Antoniou Katerina M. Eur Respir Rev 2015; 24: 428-435
Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation Caminati Antonella, Madotto Fabiana, Cesana Giancarlo, Conti Sara, Harari Sergio Eur Respir Rev 2015; 24: 436-444
ERS/ELS/ACCP 2013 international consensus conference nomenclature on inducible laryngeal obstructions Christensen Pernille M., Heimdal John-Helge, Christopher Kent L., Bucca Caterina, Cantarella Giovanna, Friedrich Gerhard, Halvorsen Thomas, Herth Felix, Jung Harald, Morris Michael J., Remacle Marc, Rasmussen Niels, Wilson Janet A. Eur Respir Rev 2015; 24: 445-450
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis Cazzola Mario, Calzetta Luigino, Page Clive, Jardim Josè, Chuchalin Alexander G., Rogliani Paola, Gabriella Matera Maria Eur Respir Rev 2015; 24: 451-461
Environmental exposure to pesticides and respiratory health Mamane Ali, Raherison Chantal, Tessier Jean-François, Baldi Isabelle, Bouvier Ghislaine Eur Respir Rev 2015; 24: 462-473
National and regional asthma programmes in Europe Selroos Olof, Kupczyk Maciej, Kuna Piotr, ?acwik Piotr, Bousquet Jean, Brennan David, Palkonen Susanna, Contreras Javier, FitzGerald Mark, Hedlin Gunilla, Johnston Sebastian L., Louis Renaud, Metcalf Leanne, Walker Samantha, Moreno-Galdó Antonio, Papadopoulos Nikolaos G., Rosado-Pinto José, Powell Pippa, Haahtela Tari Eur Respir Rev 2015; 24: 474-483
Developments in the management and treatment of pulmonary embolism Limbrey Rachel, Howard Luke Eur Respir Rev 2015; 24: 484-497
Informal caregivers of patients with COPD: Home Sweet Home? Nakken Nienke, Janssen Daisy J.A., van den Bogaart Esther H.A., Wouters Emiel F.M., Franssen Frits M.E., Vercoulen Jan H., Spruit Martijn A. Eur Respir Rev 2015; 24: 498-504
The heterogeneity of lung macrophages in the susceptibility to disease Morales-Nebreda Luisa, Misharin Alexander V., Perlman Harris, Budinger G.R. Scott Eur Respir Rev 2015; 24: 505-509
Macrophage adaptation in airway inflammatory resolution Kaur Manminder, Bell Thomas, Salek-Ardakani Samira, Hussell Tracy Eur Respir Rev 2015; 24: 510-515
Therapeutic strategies in pneumonia: going beyond antibiotics Müller-Redetzky Holger, Lienau Jasmin, Suttorp Norbert, Witzenrath Martin Eur Respir Rev 2015; 24: 516-524
Should lung biopsies be performed in patients with severe asthma? Doberer Daniel, Trejo Bittar Humberto E., Wenzel Sally E. Eur Respir Rev 2015; 24: 525-539
A rare case of diffuse pulmonary ossification Jambeih Rami, Sawh Ravindranauth Eur Respir Rev 2015; 24: 540-541
Inhalation challenge in the differential diagnosis of usual interstitial pneumonia Muñoz Xavier, Sanchez-Ortíz Monica, Ojanguren Inigo, Cruz María Jesús Eur Respir Rev 2015; 24: 542-544
“Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238. Eur Respir Rev 2015; 24: 545
“Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. Eur Respir Rev 2015; 24: 545